CIK 0001124105 · Accelerated filer<br>Smaller reporting company
GYRE THERAPEUTICS, INC.
Sign in to watch- Ticker
- GYRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562020050
- Phone
- (858) 284-0115
- Business address
- 12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
- Former names
- CATALYST BIOSCIENCES, INC., TARGACEPT INC
- 8-K Event Material agreement · Acquisition or sale completed
- DFAN14A Other Proxy Soliciting Materials
- SC 13D/A Stake Beneficial Ownership Report
- PRRN14A Other PRRN14A
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- UPLOAD Other SEC-generated Letter
- DFAN14A Other Proxy Soliciting Materials
- SC 13D/A Stake Beneficial Ownership Report
- 10-K/A Report 10-K/A
- PREC14A Other PREC14A
- DFAN14A Other Proxy Soliciting Materials
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Results of operations · Exit or restructuring costs · Executive or director change
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- DFAN14A Other Proxy Soliciting Materials
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Agreement ended
- DFAN14A Other Proxy Soliciting Materials
Page 19 of 81 · 1,604 filings